Biologically-Active Medical Devices Manufactured from Blood Plasma

Carmell Therapeutics is developing biologically-active medical devices, with growth and regenerative factors designed by nature in the right proportions to heal tissues.


8/22/14   Natural Infection Reduction: first reported use of a novel blood plasma-based product for treating open tibia fractures   August 21, 2014 – Military Health System Research Symposium (MHSRS), Fort Lauderdale, FL – Dr. Jason Smith, Director of Research and Development a[...]
5/19/14   Carmell Therapeutics Receives NIH Phase I Grant to develop antimicrobial-eluting bioresorbable bone filler.   May 19, 2014 – PITTSBURGH -- Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accel[...]
4/1/14   Carmell Innovation Showcase Winner at ACA 2014 Summit   With the largest gathering of angel investors from around the world present, the Angel Capital Association's (ACA) 2014 Summit featured presentations [...]
9/26/13   September 10, 2013: Five new U.S. Patents issued   Five new U.S. Patents have issued bringing to a total of 6 issued patents with additional U.S. and foreign applications. These five patents (8,529,95[...]